ID: ALA1270044

Max Phase: Preclinical

Molecular Formula: C14H11Br3O5

Molecular Weight: 498.95

Molecule Type: Small molecule

Representations

Canonical SMILES:  Oc1cc(Br)c(COCc2cc(O)c(O)c(Br)c2Br)cc1O

Standard InChI:  InChI=1S/C14H11Br3O5/c15-8-3-10(19)9(18)1-6(8)4-22-5-7-2-11(20)14(21)13(17)12(7)16/h1-3,18-21H,4-5H2

Standard InChI Key:  CFWIAMPRQNGELY-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 498.95

Molecular Weight (Monoisotopic): 495.8157

AlogP: 4.51

#Rotatable Bonds: 4

Polar Surface Area: 90.15

Molecular Species: NEUTRAL

HBA: 5

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 7.49

CX Basic pKa:

CX LogP: 4.67

CX LogD: 4.40

Aromatic Rings: 2

Heavy Atoms: 22

QED Weighted: 0.47

Np Likeness Score: 0.79

References

1. Oh KB, Jeon HB, Han YR, Lee YJ, Park J, Lee SH, Yang D, Kwon M, Shin J, Lee HS..  (2010)  Bromophenols as Candida albicans isocitrate lyase inhibitors.,  20  (22): [PMID:20888765] [10.1016/j.bmcl.2010.09.015]

Source

Source(1):

• Scientific Literature